173
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target

, &
Pages 603-619 | Received 27 Jan 2022, Accepted 10 Sep 2022, Published online: 10 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Koyeli Girigoswami, Pragya Pallavi & Agnishwar Girigoswami. (2023) Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum. Drug Delivery 30:1.
Read now

Articles from other publishers (3)

Chanchal Sharma & Avijit Mazumder. (2024) A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease. Central Nervous System Agents in Medicinal Chemistry 24:1, pages 45-56.
Crossref
Amir Saeed, Talal Alharazi, Khalid Alshaghdali, Raja Rezgui, Ibtihag Elnaem, Bunder Albdullah T. Alreshidi, Munazzah Tasleem & Mohd Saeed. (2024) Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects. Journal of Alzheimer's Disease 97:3, pages 1299-1312.
Crossref
Joe M. McCord, Bifeng Gao & Brooks M. Hybertson. (2023) The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review. Antioxidants 12:2, pages 366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.